CORRESP 1 filename1.htm corresp
 

(CHEMBIO DIAGNOSTICS, INC. LOGO)
January 31, 2007
BY FACSIMILE (202) 772-9217 AND EDGAR
Mr. Jeffrey P. Riedler
Division of Corporation Finance
U.S. Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549-0405
     
Re:
  Chembio Diagnostics, Inc.
 
  Amendment No. 2 to Registration Statement on Form SB-2
 
  File Number 333-138266
Dear Mr. Riedler:
     Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Chembio Diagnostics, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that the Registration Statement may become effective at 2:00 p.m. Eastern Time on Friday, February 2, 2007, or at such later time as the Company may request by telephone to the Commission.
     The Company hereby confirms that it is aware of its obligations under the Securities Act and the Securities Exchange Act of 1934, as amended, with respect to the registration of securities specified in the above-referenced Registration Statement. Further, the Company acknowledges that:
  should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
 
  the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
 
  the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
3661 Horse block Road, Medford New York 11763 USA
Tel: (631) 924-1135 Fax: (631) 924-6033 E-Mail: info@chembio.com Website: www.chembio.com

 


 

(CHEMBIO DIAGNOSTICS, INC. LOGO)
     If you or any member of the Staff has comments or questions, please contact our counsel at Patton Boggs, LLP, Alan Talensick at (303) 894-6378 or James Muchmore at (303) 894-6154.
         
  Very truly yours,

CHEMBIO DIAGNOSTICS, INC.
 
 
  By:   /s/ Lawrence A. Siebert    
    Lawrence A. Siebert, Chief Executive Officer   
       
 
Cc: Song P. Brandon
3661 Horse block Road, Medford New York 11763 USA
Tel: (631) 924-1135 Fax: (631) 924-6033 E-Mail: info@chembio.com Website: www.chembio.com